Literature DB >> 19372482

HRRT versus HR+ human brain PET studies: an interscanner test-retest study.

Floris H P van Velden1, Reina W Kloet, Bart N M van Berckel, Fred L Buijs, Gert Luurtsema, Adriaan A Lammertsma, Ronald Boellaard.   

Abstract

UNLABELLED: The high-resolution research tomograph (HRRT) is a dedicated human brain PET scanner. The purpose of this study was to compare the quantitative accuracy of the HRRT with that of the clinical HR+ PET scanner and to assess effects of differences in spatial resolution between both scanners ( approximately 2.7 mm and approximately 7.0 mm for HRRT and HR+, respectively).
METHODS: Paired (11)C-flumazenil scans of 7 healthy volunteers were assessed. For each volunteer, dynamic scans (including arterial sampling) were acquired on both scanners on the same day, thereby minimizing intersubject variability. Volume of distribution was generated using Logan plot analysis with plasma input. In addition, other plasma input, reference tissue (with pons as the reference tissue input), and parametric methods were included in the interscanner comparison.
RESULTS: Logan volume-of-distribution analysis of HRRT data showed higher values than that of HR+ data (slope with the intercept fixed at the origin of 1.14 +/- 0.10 to 1.19 +/- 0.10, depending on the HRRT reconstruction method used). Smoothing HRRT reconstructions with a 6-mm full width at half maximum gaussian kernel reduced this slope toward the line of identity (1.04 +/- 0.11 to 1.07 +/- 0.11), retaining good correlation between HR+ and HRRT data (r, approximately 0.98). Similar trends were observed for other plasma input, reference tissue, and parametric methods. However, after reference matching the reference tissue models showed lower HRRT kinetic parameter values than HR+ values (slope with fixed intercept, 0.90 +/- 0.10 to 0.94 +/- 0.13).
CONCLUSION: Higher values of pharmacokinetic parameter values, obtained from HRRT versus HR+ PET studies, indicate improved HRRT PET quantification primarily due to a reduction in partial-volume effects.

Entities:  

Mesh:

Year:  2009        PMID: 19372482     DOI: 10.2967/jnumed.108.058628

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

1.  Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.

Authors:  Rajesh Narendran; N Scott Mason; Maureen A May; Chi-Min Chen; Steve Kendro; Khanum Ridler; Eugenii A Rabiner; Marc Laruelle; Chester A Mathis; W Gordon Frankle
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

2.  Respiratory-induced errors in tumor quantification and delineation in CT attenuation-corrected PET images: effects of tumor size, tumor location, and respiratory trace: a simulation study using the 4D XCAT phantom.

Authors:  Parham Geramifar; Mojtaba Shamsaie Zafarghandi; Pardis Ghafarian; Arman Rahmim; Mohammad Reza Ay
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

3.  GABAA receptor deficits predict recovery in patients with disorders of consciousness: A preliminary multimodal [(11) C]Flumazenil PET and fMRI study.

Authors:  Pengmin Qin; Xuehai Wu; Niall W Duncan; Weiqi Bao; Weijun Tang; Zhengwei Zhang; Jin Hu; Yi Jin; Xing Wu; Liang Gao; Lu Lu; Yihui Guan; Timothy Lane; Zirui Huang; Yelena G Bodien; Joseph T Giacino; Ying Mao; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2015-07-03       Impact factor: 5.038

4.  Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.

Authors:  Martin Schain; Miklós Tóth; Zsolt Cselényi; Ryosuke Arakawa; Christer Halldin; Lars Farde; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-18       Impact factor: 9.236

5.  MR/PET or PET/MRI: does it matter?

Authors:  Thomas Beyer; Ewald Moser
Journal:  MAGMA       Date:  2013-02-06       Impact factor: 2.310

6.  Measurement of Hypothalamic Glucose Under Euglycemia and Hyperglycemia by MRI at 3T.

Authors:  James M Joers; Dinesh K Deelchand; Anjali Kumar; Amir Moheet; Elizabeth Seaquist; Pierre-Gilles Henry; Gülin Öz
Journal:  J Magn Reson Imaging       Date:  2016-07-12       Impact factor: 4.813

7.  Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.

Authors:  Floris H P van Velden; Syahir M Mansor; Daniëlle M E van Assema; Bart N M van Berckel; Femke E Froklage; Shaonan Wang; Robert C Schuit; Marie-Claude Asselin; Adriaan A Lammertsma; Ronald Boellaard; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

8.  Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Ling Feng; Masanori Ichise; Rupert Lanzenberger; Mark Lubberink; Ramin V Parsey; Marios Politis; Eugenii A Rabiner; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; Peter S Talbot; Federico Turkheimer; Stephen C Strother; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-13       Impact factor: 6.200

9.  PET image super-resolution using generative adversarial networks.

Authors:  Tzu-An Song; Samadrita Roy Chowdhury; Fan Yang; Joyita Dutta
Journal:  Neural Netw       Date:  2020-02-03

10.  In vivo validation of reconstruction-based resolution recovery for human brain studies.

Authors:  Jurgen E M Mourik; Mark Lubberink; Floris H P van Velden; Reina W Kloet; Bart N M van Berckel; Adriaan A Lammertsma; Ronald Boellaard
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-21       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.